U.S.-Africa Health Deals: Controversies and Concerns
Published on: Feb. 26, 2026, 11:12 p.m. | Source: Devdiscourse
The Africa Centres for Disease Control and Prevention voices concerns on U.S.-Africa health deals, focusing on data and pathogen sharing. Zimbabwe and Zambia push back on agreements, highlighting unequal terms. The U.S. strategy aims for direct funding, igniting debate on sovereignty and fair pharmaceutical distribution.
